Biotech · Private company
EndoCeutics Inc.
Track this companyFree. Adds EndoCeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Prasterone 6.5 mg (0.50%) Vaginal InsertPhase 3 · Hypoactive Sexual Desire DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Prasterone 6.5 mg (0.50%) Vaginal InsertPhase 3 · Hypoactive Sexual Desire Disorder (HSDD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second StudyPHASE3 · WITHDRAWN · started Nov 13, 2018ClinicalTrials.gov NCT03619005 · fetched Nov 12, 2026
- Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)PHASE3 · COMPLETED · started Oct 16, 2017ClinicalTrials.gov NCT03287232 · fetched Nov 12, 2026